Compare
Vicarious Surgical Inc. vs Lifeward Ltd. vs CollPlant Biotechnologies Ltd vs Myomo, Inc.
| Latest fiscal year | Vicarious Surgical Inc. RBOT | Lifeward Ltd. LFWD | CollPlant Biotechnologies Ltd OPHI | Myomo, Inc. MYO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $22.03M | $2.37M | $40.93M |
| Revenue growth (YoY) | n/a | -14.1% | +360.4% | +25.7% |
| Gross margin | n/a | 38.2% | 64.8% | 65.7% |
| Operating margin | n/a | -89.3% | -484.3% | -35.2% |
| Net margin | n/a | -90.4% | -484.6% | -38.1% |
| Net income | -$50.18M | -$19.91M | -$11.49M | -$15.57M |
| EPS (Diluted) | n/a | -$17.16 | -$0.94 | -$0.37 |
| Operating cash flow | -$45.08M | -$16.83M | -$9.42M | -$14.51M |
| Free cash flow | -$45.21M | -$16.84M | -$9.45M | -$16.25M |
| Cash & equivalents | $2.57M | $2.17M | $5.59M | $14.13M |
| Total assets | $19.58M | $22.90M | $10.79M | $38.64M |
| Total liabilities | $9.74M | $14.49M | $4.70M | $27.23M |
| Shareholders' equity | $9.84M | $8.41M | $6.08M | $11.40M |
| Return on year-end equity | -509.9% | -236.8% | -188.9% | -136.6% |
| Shares outstanding | n/a | 1.52M | 12.80M | 38.47M |
Revenue, most recent five fiscal years
| Fiscal year | Vicarious Surgical Inc. | Lifeward Ltd. | CollPlant Biotechnologies Ltd | Myomo, Inc. |
|---|---|---|---|---|
| Latest | n/a | $22.03M Ended 2025-12-31 | $2.37M Ended 2025-12-31 | $40.93M Ended 2025-12-31 |
| 1 year earlier | n/a | $25.66M Ended 2024-12-31 | $515.0K Ended 2024-12-31 | $32.55M Ended 2024-12-31 |
| 2 years earlier | n/a | $13.85M Ended 2023-12-31 | $10.96M Ended 2023-12-31 | $19.24M Ended 2023-12-31 |
| 3 years earlier | n/a | $5.51M Ended 2022-12-31 | $299.0K Ended 2022-12-31 | $15.56M Ended 2022-12-31 |
| 4 years earlier | n/a | $5.97M Ended 2021-12-31 | $15.64M Ended 2021-12-31 | $13.86M Ended 2021-12-31 |